Tatsuya Moriyama Selected Research

Tatsuya Moriyama Research Topics

Disease

9	Rupture 01/2020 - 01/2015
8	Abdominal Aortic Aneurysm 07/2022 - 06/2016
8	Hypersensitivity (Allergy) 01/2020 - 12/2007
7	Obesity 10/2021 - 08/2003
6	Food Hypersensitivity (Food Allergy) 04/2022 - 01/2015
4	Anaphylaxis (Anaphylactic Shock) 01/2022 - 02/2009
3	Aneurysm (Aneurysms) 06/2018 - 01/2016
3	Body Weight (Weight, Body) 01/2018 - 01/2016
2	Inflammation (Inflammations) 04/2022 - 12/2021
2	Weight Gain 01/2022 - 01/2016
2	Atherosclerosis 11/2021 - 02/2004
2	Osteoporosis 11/2019 - 10/2017
2	Breast Neoplasms (Breast Cancer) 11/2019 - 01/2012
2	Type 2 Diabetes Mellitus (MODY) 05/2013 - 01/2012
2	Hyperinsulinism (Hyperinsulinemia) 02/2004 - 08/2003
2	Hyperglycemia 02/2004 - 08/2003
1	Pneumonia (Pneumonitis) 07/2022
1	Asthma (Bronchial Asthma) 07/2022
1	Vascular Diseases (Vascular Disease) 11/2021
1	Alzheimer Disease (Alzheimer's Disease) 09/2021
1	Hepatocellular Carcinoma (Hepatoma) 06/2021
1	Dementia (Dementias) 01/2019
1	Fatty Liver 05/2018
1	Asthenopia (Eyestrain) 03/2018
1	Chronic Obstructive Pulmonary Disease (COPD) 09/2016
1	Obstructive Sleep Apnea 09/2016
1	Rheumatoid Arthritis 09/2016
1	Coronary Artery Disease (Coronary Atherosclerosis) 09/2016
1	Hypertrophy 01/2016
1	Immediate Hypersensitivity 01/2015
1	Dyslipidemias (Dyslipidemia) 05/2013
1	Bone Resorption 12/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2011
1	Hyperlipidemias (Hyperlipidemia) 06/2011
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 06/2005
1	Non-alcoholic Fatty Liver Disease 06/2005
1	Hypertriglyceridemia 02/2004

Drug/Important Bio-Agent (IBA)

12	AllergensIBA 04/2022 - 02/2009
6	Immunoglobulin E (IgE)IBA 01/2021 - 12/2007
5	Nicotine FDA Link 01/2020 - 08/2017
4	ResistinIBA 12/2018 - 08/2003
4	LipidsIBA 05/2017 - 06/2005
4	Proteins (Proteins, Gene)FDA Link 01/2016 - 02/2010
3	Eicosapentaenoic AcidIBA 07/2022 - 04/2021
3	Estrogens (Estrogen)FDA Link 10/2021 - 01/2012
3	puerarinIBA 01/2016 - 01/2012
2	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 01/2016
2	EnzymesIBA 09/2021 - 08/2003
2	Matrix Metalloproteinases (MMPs)IBA 12/2019 - 01/2016
2	SmokeIBA 01/2019 - 08/2017
2	Fish OilsIBA 06/2016 - 01/2016
2	AdipokinesIBA 05/2013 - 01/2012
2	royal jellyIBA 11/2011 - 06/2011
1	Prednisolone (Predate)FDA LinkGeneric 07/2022
1	CytokinesIBA 04/2022
1	lipid transfer protein (glycolipid transfer protein)IBA 01/2022
1	A-factor (Streptomyces)IBA 11/2021
1	syringic acidIBA 10/2021
1	Volatile Oils (Essential Oils)IBA 09/2021
1	Sulfur Compounds (Compounds, Sulfur)IBA 09/2021
1	Ellagic AcidIBA 06/2021
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 06/2021
1	Apolipoproteins B (ApoB)IBA 06/2021
1	AntibodiesIBA 01/2021
1	AntigensIBA 01/2020
1	Leukocyte Elastase (Neutrophil Elastase)IBA 12/2019
1	Endothelin-1 (Endothelin 1)IBA 12/2019
1	Angiotensin IIIBA 12/2019
1	IsoflavonesIBA 12/2019
1	AngiotensinogenIBA 12/2019
1	Estrogen ReceptorsIBA 11/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Amyloid (Amyloid Fibrils)IBA 01/2019
1	soyasapogenol BIBA 12/2018
1	Triglycerides (Triacylglycerol)IBA 12/2018
1	Sucrose (Saccharose)IBA 05/2018
1	Anthocyanins (Anthocyanin)IBA 03/2018
1	GlycosidesIBA 01/2018
1	Testosterone (Sustanon)FDA Link 09/2016
1	TrioleinIBA 01/2016
1	TaheeboIBA 01/2016
1	AntioxidantsIBA 01/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	Ethanol (Ethyl Alcohol)IBA 01/2016
1	CollagenIBA 01/2015
1	Troponin CIBA 08/2012
1	Tartrate-Resistant Acid PhosphataseIBA 12/2011
1	deoxypyridinolineIBA 12/2011
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2011
1	BezafibrateIBA 06/2011
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2011
1	Olive OilIBA 06/2011
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 06/2005
1	Dietary ProteinsIBA 02/2004

Therapy/Procedure

2	Oral Administration 01/2022 - 06/2011
2	Ovariectomy (Oophorectomy) 10/2021 - 12/2019
2	Chemoprevention 11/2019 - 10/2017
1	Drug Therapy (Chemotherapy) 06/2018
1	Therapeutics 05/2018
1	Aftercare (After-Treatment) 02/2009